5-ethynyl-1-ribofuranosylimidazole-4-carboxamide has been researched along with Birnaviridae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Clercq, E; Jashés, M; Mlynarz, G; Sandino, AM | 1 |
| De Clercq, E; Jashés, M; Moya, J; Pizarro, H; Sandino, AM | 1 |
2 other study(ies) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and Birnaviridae Infections
| Article | Year |
|---|---|
Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication.
Topics: Animals; Antiviral Agents; Birnaviridae Infections; Cell Line; Guanosine; Infectious pancreatic necrosis virus; Ribonucleosides; RNA, Messenger; RNA, Viral; Salmon; Transcription, Genetic; Viral Proteins; Virus Replication | 2000 |
In vivo effect of EICAR (5-ethynyl-1-beta-D-ribofuranosylimidazole-carboxamide) on experimental infected rainbow trout (Oncorhynchus mykiss) and coho salmon (Oncorhynchus kisutch) fry with infectious pancreatic necrosis virus.
Topics: Animals; Antiviral Agents; Birnaviridae Infections; Fish Diseases; Infectious pancreatic necrosis virus; Oncorhynchus kisutch; Oncorhynchus mykiss; Ribonucleosides | 2000 |